We are accelerating drug discovery to deliver treatments to patients faster. Our powerful engine integrates combinatorial chemistry, pico-scale activity-based screening, and AI, generating millions of empirical datapoints every week to evolve our models. This enables our biologists and medicinal chemists to discover novel small molecule therapeutics rapidly.
| Website | https://1859.ai/ |
| Employees | 27 (3 on RocketReach) |
| Founded | 2019 |
| Address | 11425 Sorrento Valley Road Suite 2, San Diego, California 92121, US |
| Phone | +1 954-357-0957 |
| Industry | Biotechnology Research |
| Keywords | Drug Discovery, Accelerated Drug Development, Ai Drug Discovery, Machine Learning Drug Discovery, Combinatorial Chemistry, Therapeutic Innovation, High Throughput Screening, Drug Design, Pharmaceutical Research, Pharmaceutical Ai, Biotechnology, Clinical Development, Precision Medicine, Life Sciences, Genomics, Proteomics, Molecular Modeling, Cheminformatics, Drug Target Identification |
| Competitors | Amazon, Microsoft, IBM, Palantir Technologies, Databricks, SAS, DataRobot, H2O.ai, AI Community, Altair RapidMiner +38 more (view full list) |
Looking for a particular 1859 employee's phone or email?
Adam Kallel is the Senior Director of Computational Chemistry of 1859.
3 people are employed at 1859.
1859 is based in San Diego, California.